[go: up one dir, main page]

AR045911A1 - Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides - Google Patents

Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides

Info

Publication number
AR045911A1
AR045911A1 ARP040102492A ARP040102492A AR045911A1 AR 045911 A1 AR045911 A1 AR 045911A1 AR P040102492 A ARP040102492 A AR P040102492A AR P040102492 A ARP040102492 A AR P040102492A AR 045911 A1 AR045911 A1 AR 045911A1
Authority
AR
Argentina
Prior art keywords
self
formulations
oral administration
taxoids
microemulsionable
Prior art date
Application number
ARP040102492A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR045911A1 publication Critical patent/AR045911A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administración oral de taxoides. Nuevas formulaciones de taxoides para administración oral. Reivindicación 1: Una formulación auto-microemulsionable para la administración oral de taxoides, que comprende al menos un taxoide, al menos un co-tensioactivo, al menos un aceite y un tensioactivo (Cremophor EL®). Reivindicación 11: Una formulación auto-microemulsionable según las reivindicaciones 1 a 10, donde la formulación comprende 60 % de Crempohor EL, 20 % de Imwitor 888 y 20 % de Miglycol 812N (porcentaje en peso).
ARP040102492A 2003-07-18 2004-07-15 Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides AR045911A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291798A EP1498143A1 (en) 2003-07-18 2003-07-18 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids

Publications (1)

Publication Number Publication Date
AR045911A1 true AR045911A1 (es) 2005-11-16

Family

ID=33462261

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040102492A AR045911A1 (es) 2003-07-18 2004-07-15 Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides

Country Status (16)

Country Link
US (2) US20050025792A1 (es)
EP (2) EP1498143A1 (es)
JP (1) JP2009513557A (es)
KR (1) KR20060052834A (es)
CN (1) CN100566758C (es)
AR (1) AR045911A1 (es)
AT (1) ATE405293T1 (es)
AU (1) AU2004262495B2 (es)
BR (1) BRPI0412740A (es)
CA (1) CA2532566A1 (es)
DE (1) DE602004015994D1 (es)
IL (1) IL173112A0 (es)
MX (1) MXPA06000633A (es)
MY (1) MY139106A (es)
TW (1) TWI337870B (es)
WO (1) WO2005014048A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124670A1 (en) * 2005-04-20 2009-05-14 Kenichi Sakai Method for designing formulation of self-emulsifying preparation
ES2397289T3 (es) 2005-09-22 2013-03-06 Biocompatibles Uk Ltd. Polipéptidos de fusión de GLP-1 (péptido 1 de tipo glucagón) con resistencia a peptidasa incrementada
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
CA2742388C (en) * 2007-11-08 2019-02-19 Virginia Tech Intellectual Properties, Inc. Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
CN101829052B (zh) * 2010-03-16 2011-12-14 王国强 紫杉烷类化合物的自乳化制剂及其制备方法
CN102228431A (zh) * 2010-03-16 2011-11-02 王国强 紫杉烷类化合物的自乳化药物组合物
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
JP2013209294A (ja) * 2010-07-30 2013-10-10 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 液状医薬組成物
GB2488788B (en) 2011-03-07 2013-07-10 Natco Pharma Ltd Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
TWI715636B (zh) * 2015-09-30 2021-01-11 香港商慧源香港創新有限公司 口服紫杉烷組合物及方法
CN109589305B (zh) * 2018-12-03 2021-03-19 昆明积大制药股份有限公司 多西他赛-环孢素a共包载自乳化制剂及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698582A (en) * 1991-07-08 1997-12-16 Rhone-Poulenc Rorer S.A. Compositions containing taxane derivatives
DE69329430T2 (de) * 1992-10-16 2001-05-10 Ibah, Inc. Konvertierbare mikroemulsionsformulierungen
WO1994019003A1 (en) * 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions comprising therapeutic peptides
US6964946B1 (en) * 1995-10-26 2005-11-15 Baker Norton Pharmaceuticals, Inc. Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
BE1011216A3 (fr) * 1997-06-13 1999-06-01 Thissen En Abrege L T B Lab Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
KR100661879B1 (ko) * 1998-04-01 2006-12-27 스키에파마 캐나다 인코포레이티드 항암 조성물
AU4989299A (en) * 1998-07-14 2000-02-07 Em Industries, Inc. Microdisperse drug delivery systems
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
WO2001028518A1 (de) * 1999-10-20 2001-04-26 Vesifact Ag Cyclosporine enthaltende mikroemulsion-prekonzentrate und mikroemulsionen
MXPA03006404A (es) * 2001-01-18 2004-12-02 Upjohn Co Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada.
JP2004529934A (ja) * 2001-05-01 2004-09-30 アンジオテック ファーマシューティカルズ，インコーポレイテッド 抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用
WO2003045357A1 (en) * 2001-11-27 2003-06-05 Transform Pharmaceuticals, Inc. Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
EP1498120A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid formulations for the oral administration of taxoids

Also Published As

Publication number Publication date
AU2004262495B2 (en) 2011-02-03
MY139106A (en) 2009-08-28
TWI337870B (en) 2011-03-01
IL173112A0 (en) 2006-06-11
CA2532566A1 (en) 2005-02-17
BRPI0412740A (pt) 2006-09-26
US20090069411A1 (en) 2009-03-12
WO2005014048A1 (en) 2005-02-17
EP1648517B1 (en) 2008-08-20
MXPA06000633A (es) 2006-04-19
CN100566758C (zh) 2009-12-09
JP2009513557A (ja) 2009-04-02
CN1822859A (zh) 2006-08-23
EP1648517A1 (en) 2006-04-26
HK1089951A1 (zh) 2006-12-15
DE602004015994D1 (de) 2008-10-02
ATE405293T1 (de) 2008-09-15
KR20060052834A (ko) 2006-05-19
US20050025792A1 (en) 2005-02-03
EP1498143A1 (en) 2005-01-19
TW200518772A (en) 2005-06-16
AU2004262495A1 (en) 2005-02-17

Similar Documents

Publication Publication Date Title
AR045911A1 (es) Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
UY30099A1 (es) Una composicion solida de taxano liofilizado, un procedimiento para preparar dicha composicion solida, una formulacion farmacéutica y un conjunto (kit) para la preparacion de una formulacion inyectable de taxano
CO5580835A2 (es) Nuevas formulaciones analogas de ciclosporina
AR021370A1 (es) Composiciones farmaceuticas inyectables estabilizadas que contienen agentes anti-neoplasicos taxoides
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
AR037951A1 (es) Composiciones farmaceuticas de derivados de taxano oralmente activos que tienen biodisponibilidad mejorada
ES2163926T3 (es) Nanoemulsion a base de eteres grasos etoxilados o esteres grasos etoxilados, y sus utilizaciones en los ambitos cosmeticos, dermatologicos y/u oftalmologicos.
AR064614A1 (es) Producto combinado par controlar parasitos en animales
BRPI0411306A (pt) composições farmacêuticas compreendendo compostos ativos de vitamina d
CL2007003447A1 (es) Composicion lubricante que comprende un aceite base, fosfato tricalcico en concentraciones de 2 a 68% en peso relativo a la composicion total y un agente tensioactivo; y uso de dicah composicion.
BRPI0717219B8 (pt) composição imunogênica, e, uso de uma composição imunogênica
HRP20090381T1 (en) Compositions comprising drospirenone molecularly dispersed
FR2718963B1 (fr) Nouvelle composition pharmaceutique à base de taxoïdes.
PT977562E (pt) Metodos e composicoes para administracao de taxanos
AR036700A1 (es) Forma de dosificacion oral solida de simeticona
MX2022002548A (es) Composiciones medicinales estables de cannabidiol.
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
AR028703A1 (es) Aceites para el cabello
GT199900129A (es) Formulaciones liquidas de pirimetanilo y metodos para su preparacion.
CO5540294A2 (es) Una combinacion de un derivado de rapamicina y un agente alquilante seleccionado de ciclofosfamida y carmustina y composiciones que las contienen
AR037687A1 (es) Composiciones farmaceuticas a base de derivados de azetidina
CL2008003002A1 (es) Composición farmacéutica inyectable intravenosa en forma de emulsión aceite en agua que comprende al toxoide larotaxel (xrp9881) o cabazitaxel (xrp6258) disuelto en lecitina, y al tensioactivo aniónico fosfatidilglicerol o acido fosfatidico; proeceidimiento para su preparacion, útil como antineoplástico.
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
AR045996A1 (es) Formulaciones semi-solidas para la administracion oral de taxoides

Legal Events

Date Code Title Description
FA Abandonment or withdrawal